{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2026:SCJRUWXMVUTRVMCCGTV2BMPJQI","short_pith_number":"pith:SCJRUWXM","canonical_record":{"source":{"id":"2608.01007","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2026-08-02T05:23:26Z","cross_cats_sorted":[],"title_canon_sha256":"46052fd2f956ab80761c6ae8c3fea8cb2997cd08605ad49c595854a4831c5cd0","abstract_canon_sha256":"303084b8515c944826938f4f29df1c85127cf575a21ca6016b86522cbecbfc01"},"schema_version":"1.0"},"canonical_sha256":"90931a5aecad271ab04234eba0b1e982233a23ea378522072567ed0c56c2e31e","source":{"kind":"arxiv","id":"2608.01007","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2608.01007","created_at":"2026-08-04T01:56:12Z"},{"alias_kind":"arxiv_version","alias_value":"2608.01007v1","created_at":"2026-08-04T01:56:12Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2608.01007","created_at":"2026-08-04T01:56:12Z"},{"alias_kind":"pith_short_12","alias_value":"SCJRUWXMVUTR","created_at":"2026-08-04T01:56:12Z"},{"alias_kind":"pith_short_16","alias_value":"SCJRUWXMVUTRVMCC","created_at":"2026-08-04T01:56:12Z"},{"alias_kind":"pith_short_8","alias_value":"SCJRUWXM","created_at":"2026-08-04T01:56:12Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2026:SCJRUWXMVUTRVMCCGTV2BMPJQI","target":"record","payload":{"canonical_record":{"source":{"id":"2608.01007","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2026-08-02T05:23:26Z","cross_cats_sorted":[],"title_canon_sha256":"46052fd2f956ab80761c6ae8c3fea8cb2997cd08605ad49c595854a4831c5cd0","abstract_canon_sha256":"303084b8515c944826938f4f29df1c85127cf575a21ca6016b86522cbecbfc01"},"schema_version":"1.0"},"canonical_sha256":"90931a5aecad271ab04234eba0b1e982233a23ea378522072567ed0c56c2e31e","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-08-04T01:56:12.215639Z","signature_b64":"dpMWQ/WSj4haUGOjqUYQ3dpwYfA9V3XyC020Y0al0JRbI6HKN22BfYKkukp0XaZUMkjBwITa4hpmsYzCT6hGDg==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"90931a5aecad271ab04234eba0b1e982233a23ea378522072567ed0c56c2e31e","last_reissued_at":"2026-08-04T01:56:12.214157Z","signature_status":"signed_v1","first_computed_at":"2026-08-04T01:56:12.214157Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"2608.01007","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-08-04T01:56:12Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"pCoP6uztJ11umzRurd9tlrNWHRG214kqKBQX8nUMWHZ41pPoPBuy2RGYXp1JQQAD4nSpp6ypxLqfmLkv/mKmCQ==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-19T08:55:06.832290Z"},"content_sha256":"cf8f8ff0ec9f837bd0459e0cb7c54bb7b125cc5eb3358af169ffdd04da8f774f","schema_version":"1.0","event_id":"sha256:cf8f8ff0ec9f837bd0459e0cb7c54bb7b125cc5eb3358af169ffdd04da8f774f"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2026:SCJRUWXMVUTRVMCCGTV2BMPJQI","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Fused Bayesian Flow Networks for Dual-Target Molecular Design","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"cs.LG","authors_text":"Jingyuan Zhou, Lei Xu, Shikui Tu","submitted_at":"2026-08-02T05:23:26Z","abstract_excerpt":"Dual-target drug design aims to generate 3D molecules that can simultaneously interact with two target proteins, offering a promising route for discovering polypharmacological compounds against complex diseases. While recent generative models have shown encouraging performance in single-target drug design, existing dual-target approaches either focus on sequence generation or introduce an additional predictive drift term into the diffusion-based generative trajectory, which limits their ability to fully integrate feature information from both targets. We propose FusedBFN, a fused Bayesian flow"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2608.01007","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2608.01007/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-08-04T01:56:12Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"QLU53KQ/L16zU6NWtWkmTLVyKLYjfwbDllVP1ky551fxso99ta7xArJzsA+aSx0USDx7b9a8ei6XMU3QvY7hBQ==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-19T08:55:06.833251Z"},"content_sha256":"091517599f99e2370f3f6901e2b7b57f3706cd911e926742df49c12e4526cbfe","schema_version":"1.0","event_id":"sha256:091517599f99e2370f3f6901e2b7b57f3706cd911e926742df49c12e4526cbfe"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/SCJRUWXMVUTRVMCCGTV2BMPJQI/bundle.json","state_url":"https://pith.science/pith/SCJRUWXMVUTRVMCCGTV2BMPJQI/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/SCJRUWXMVUTRVMCCGTV2BMPJQI/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-08-19T08:55:06Z","links":{"resolver":"https://pith.science/pith/SCJRUWXMVUTRVMCCGTV2BMPJQI","bundle":"https://pith.science/pith/SCJRUWXMVUTRVMCCGTV2BMPJQI/bundle.json","state":"https://pith.science/pith/SCJRUWXMVUTRVMCCGTV2BMPJQI/state.json","well_known_bundle":"https://pith.science/.well-known/pith/SCJRUWXMVUTRVMCCGTV2BMPJQI/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2026:SCJRUWXMVUTRVMCCGTV2BMPJQI","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"303084b8515c944826938f4f29df1c85127cf575a21ca6016b86522cbecbfc01","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2026-08-02T05:23:26Z","title_canon_sha256":"46052fd2f956ab80761c6ae8c3fea8cb2997cd08605ad49c595854a4831c5cd0"},"schema_version":"1.0","source":{"id":"2608.01007","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2608.01007","created_at":"2026-08-04T01:56:12Z"},{"alias_kind":"arxiv_version","alias_value":"2608.01007v1","created_at":"2026-08-04T01:56:12Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2608.01007","created_at":"2026-08-04T01:56:12Z"},{"alias_kind":"pith_short_12","alias_value":"SCJRUWXMVUTR","created_at":"2026-08-04T01:56:12Z"},{"alias_kind":"pith_short_16","alias_value":"SCJRUWXMVUTRVMCC","created_at":"2026-08-04T01:56:12Z"},{"alias_kind":"pith_short_8","alias_value":"SCJRUWXM","created_at":"2026-08-04T01:56:12Z"}],"graph_snapshots":[{"event_id":"sha256:091517599f99e2370f3f6901e2b7b57f3706cd911e926742df49c12e4526cbfe","target":"graph","created_at":"2026-08-04T01:56:12Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"integrity":{"available":true,"clean":true,"detectors_run":[],"endpoint":"/pith/2608.01007/integrity.json","findings":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938","summary":{"advisory":0,"by_detector":{},"critical":0,"informational":0}},"paper":{"abstract_excerpt":"Dual-target drug design aims to generate 3D molecules that can simultaneously interact with two target proteins, offering a promising route for discovering polypharmacological compounds against complex diseases. While recent generative models have shown encouraging performance in single-target drug design, existing dual-target approaches either focus on sequence generation or introduce an additional predictive drift term into the diffusion-based generative trajectory, which limits their ability to fully integrate feature information from both targets. We propose FusedBFN, a fused Bayesian flow","authors_text":"Jingyuan Zhou, Lei Xu, Shikui Tu","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2026-08-02T05:23:26Z","title":"Fused Bayesian Flow Networks for Dual-Target Molecular Design"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2608.01007","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:cf8f8ff0ec9f837bd0459e0cb7c54bb7b125cc5eb3358af169ffdd04da8f774f","target":"record","created_at":"2026-08-04T01:56:12Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"303084b8515c944826938f4f29df1c85127cf575a21ca6016b86522cbecbfc01","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.LG","submitted_at":"2026-08-02T05:23:26Z","title_canon_sha256":"46052fd2f956ab80761c6ae8c3fea8cb2997cd08605ad49c595854a4831c5cd0"},"schema_version":"1.0","source":{"id":"2608.01007","kind":"arxiv","version":1}},"canonical_sha256":"90931a5aecad271ab04234eba0b1e982233a23ea378522072567ed0c56c2e31e","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"90931a5aecad271ab04234eba0b1e982233a23ea378522072567ed0c56c2e31e","first_computed_at":"2026-08-04T01:56:12.214157Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-08-04T01:56:12.214157Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"dpMWQ/WSj4haUGOjqUYQ3dpwYfA9V3XyC020Y0al0JRbI6HKN22BfYKkukp0XaZUMkjBwITa4hpmsYzCT6hGDg==","signature_status":"signed_v1","signed_at":"2026-08-04T01:56:12.215639Z","signed_message":"canonical_sha256_bytes"},"source_id":"2608.01007","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:cf8f8ff0ec9f837bd0459e0cb7c54bb7b125cc5eb3358af169ffdd04da8f774f","sha256:091517599f99e2370f3f6901e2b7b57f3706cd911e926742df49c12e4526cbfe"],"state_sha256":"047637c7e3984f8d47d94b580ccad48d11adfe7735baca56ba3c676793d369af"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"a9qb0AyuDd6udTprQCQc2uTULEKoItdkGcn41PJhv3n3rhZ7EKt48uPpXQVQEJnINlgF0qGoJxqvOQr82FYiAQ==","signed_message":"bundle_sha256_bytes","signed_at":"2026-08-19T08:55:06.840013Z","bundle_sha256":"ac61dca4813ce3c4f4141ab4043087b0ec87a299cb7765868ecfb17079a52e36"}}